2023
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists
Harms P, Frankel T, Moutafi M, Rao A, Rimm D, Taube J, Thomas D, Chan M, Pantanowitz L. Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists. Modern Pathology 2023, 36: 100197. PMID: 37105494, DOI: 10.1016/j.modpat.2023.100197.Peer-Reviewed Original ResearchConceptsDigital spatial profilingMost clinical laboratoriesTumor microenvironmentImmunofluorescence/immunohistochemistryImmuno-oncology researchDiagnostic practiceClinical laboratoriesRoutine diagnostic useAntitumor immunityAdvanced cancerImmune populationsMultiplex stainingEosin stainingIHC stainsPractical updateClinical diagnostic practiceMultiplex immunohistochemistrySingle biomarkerImmunohistochemistryMultiplexed immunohistochemistryStandardized protocolChromogenic immunohistochemistryDiagnostic useMultiple biomarkersSerial sections
2018
Comparison of Biomarker Expressivity in the Esophageal Metaplasia-Dysplasia-Adenocarcinoma Sequence
Sostin N, Sostin O, Fiedler P, Campbell J. Comparison of Biomarker Expressivity in the Esophageal Metaplasia-Dysplasia-Adenocarcinoma Sequence. American Journal Of Clinical Pathology 2018, 150: s52-s52. DOI: 10.1093/ajcp/aqy090.128.Peer-Reviewed Original ResearchHigh-grade dysplasiaLow-grade dysplasiaHigh-risk lesionsEsophageal adenocarcinomaIHC stainsCyclin D1Invasive adenocarcinomaTissue microarrayMucosal biopsy specimensDepartment of PathologyP53 staining patternMucosal biopsiesDanbury HospitalHistologic diagnosisBiopsy specimensEsophageal dysplasiaMetaplasia-dysplasiaImmunohistochemical stainsClinical utilityBiopsy tissueLethal cancersPositive stainingAdenocarcinomaAdenocarcinoma sequenceIntensity staining
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply